Hair loss is a common concern for many people, especially male pattern baldness (androgenetic alopecia). However, in clinical practice, doctors have observed an interesting phenomenon: when a small piece of hair follicles is taken from the occipital (back of the scalp) area and transplanted to the balding forehead or crown, these follicles not only fail to continue shedding but can also grow healthily for the long term. The scientific principle behind this is the classic “donor dominance theory.”
The donor dominance theory was first proposed by American dermatologist Norman Orentreich in the 1950s. The core idea of this theory is that the lifespan and growth characteristics of hair follicles are primarily determined by their own genetic properties, rather than depending on the environment of the recipient area. In other words, transplanted follicles still “remember” where they came from and continue to operate according to their original growth rhythm.
Why are hair follicles from the occipital area so “distinctive”? The key lies in their sensitivity to androgens—especially dihydrotestosterone (DHT). The root cause of androgenetic alopecia is that hair follicles on the forehead and crown carry a large number of androgen receptors. When testosterone is converted into DHT by the enzyme 5α-reductase, DHT binds to these receptors, gradually miniaturizing the follicles and eventually causing them to shed. In contrast, hair follicles in the occipital area naturally have extremely low densities of androgen receptors and are almost “unresponsive” to DHT.
This difference stems from the embryonic development and gene expression of the follicles. Studies have shown that the expression levels of androgen receptor genes in occipital hair follicles are significantly lower than those in the crown area, and local 5α-reductase activity is also lower. Therefore, even when systemic androgen levels are normal, occipital hair follicles are not attacked, allowing them to maintain their full growth cycle, which can last for decades or even a lifetime.
The most direct evidence for the donor dominance theory comes from autologous hair transplant surgery. Surgeons extract a thin strip of follicular units from the patient’s occipital area, micro-dissect them, and implant them into the balding area. Long-term follow-up shows that the transplanted hair retains the original characteristics of the occipital area in the recipient site: unaffected by androgens, no shedding, and continued growth. This is a clinical validation of the donor dominance theory.
It should be emphasized that the donor dominance theory does not mean that all occipital hair follicles are “immortal.” In rare cases, some transplanted follicles may shed prematurely due to surgical trauma, infection, or individual immune responses. Additionally, if the patient has other types of hair loss (such as alopecia areata, lichen planopilaris, etc.), the transplanted follicles may also be affected by the underlying disease. Therefore, this theory primarily applies to androgenetic alopecia.
In recent years, with advances in molecular biology, scientists are searching for specific genes and signaling pathways that control the “donor dominance” of hair follicles. For example, polymorphisms in certain genes (such as *AR*, *SRD5A2*, etc.) may determine the resistance of occipital hair follicles. However, these studies are still in the exploratory phase and have not yet been translated into clinical treatments.
In summary, the donor dominance theory provides a solid scientific foundation for hair transplantation. It tells us that because occipital hair follicles are insensitive to androgens, they can serve as ideal “donors,” providing permanent hair growth for balding areas. However, individual differences in follicular characteristics exist, and transplant outcomes should be evaluated by a professional physician.
**For reference only, not medical advice.**